STRS Ohio’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-31,316
| Closed | -$1.28M | – | 2097 |
|
2024
Q2 | $1.28M | Buy |
31,316
+18,316
| +141% | +$749K | 0.01% | 792 |
|
2024
Q1 | $549K | Buy |
13,000
+3,200
| +33% | +$135K | ﹤0.01% | 1193 |
|
2023
Q4 | $415K | Sell |
9,800
-400
| -4% | -$16.9K | ﹤0.01% | 1355 |
|
2023
Q3 | $222K | Hold |
10,200
| – | – | ﹤0.01% | 1543 |
|
2023
Q2 | $324K | Buy |
10,200
+6,300
| +162% | +$200K | ﹤0.01% | 1456 |
|
2023
Q1 | $95K | Hold |
3,900
| – | – | ﹤0.01% | 1722 |
|
2022
Q4 | $123K | Hold |
3,900
| – | – | ﹤0.01% | 1696 |
|
2022
Q3 | $110K | Buy |
3,900
+2,300
| +144% | +$64.9K | ﹤0.01% | 1736 |
|
2022
Q2 | $42K | Hold |
1,600
| – | – | ﹤0.01% | 1882 |
|
2022
Q1 | $56K | Hold |
1,600
| – | – | ﹤0.01% | 1931 |
|
2021
Q4 | $51K | Hold |
1,600
| – | – | ﹤0.01% | 2004 |
|
2021
Q3 | $47K | Sell |
1,600
-6,600
| -80% | -$194K | ﹤0.01% | 2080 |
|
2021
Q2 | $210K | Buy |
+8,200
| New | +$210K | ﹤0.01% | 1804 |
|